JOHN R GAILEY Insider Trading $WST WEST PHARMACEUTICAL SERVICES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN R GAILEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN R GAILEY. JOHN R GAILEY is VP, Gen. Counsel & Sec. in WEST PHARMACEUTICAL SERVICES INC ($WST).
JOHN R GAILEY in WEST PHARMACEUTICAL SERVICES INC
Industry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of JOHN R GAILEY: VP, Gen. Counsel & Sec.
Holdings: 24,257 shares
Current Value: $2,077,855
Latest Transaction: Dec 03 2012
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN R GAILEY in WEST PHARMACEUTICAL SERVICES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2012 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 25.53 | 11,000 | 280,830 | 0 | |
| Dec 03 2012 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 53.81 | 11,000 | 591,930 | 24,257 | 35.3 K to 24.3 K (-31.20 %) |
| Dec 03 2012 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 25.53 | 11,000 | 280,830 | 35,257 | 24.3 K to 35.3 K (+45.35 %) |
| Feb 23 2012 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 42.44 | 18,916 | 802,795 | 18,916 | |
| Feb 23 2012 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 42.44 | 1,567 | 66,503 | 24,691 | 23.1 K to 24.7 K (+6.78 %) |
| May 04 2011 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 19.37 | 14,600 | 282,729 | 0 | |
| May 04 2011 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 46.92 | 14,600 | 685,035 | 23,102 | 37.7 K to 23.1 K (-38.72 %) |
| May 04 2011 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 19.37 | 14,600 | 282,729 | 37,702 | 23.1 K to 37.7 K (+63.20 %) |
| Feb 24 2011 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 40.85 | 17,123 | 699,475 | 17,123 | |
| Feb 24 2011 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.85 | 1,481 | 60,499 | 23,102 | 21.6 K to 23.1 K (+6.85 %) |
| Mar 23 2010 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 42.68 | 18,916 | 807,335 | 18,916 | |
| Mar 01 2010 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Payment of Exercise | F | 38.65 | 41 | 1,585 | 21,621 | 21.7 K to 21.6 K (-0.19 %) |
| Feb 23 2010 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 38.22 | 1,300 | 49,686 | 21,662 | 20.4 K to 21.7 K (+6.38 %) |
| Aug 19 2009 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 13.02 | 28,800 | 374,852 | 0 | |
| Aug 19 2009 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 39.21 | 28,800 | 1,129,133 | 20,362 | 49.2 K to 20.4 K (-58.58 %) |
| Aug 19 2009 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 13.02 | 28,800 | 374,852 | 49,162 | 20.4 K to 49.2 K (+141.44 %) |
| Mar 06 2009 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Payment of Exercise | F | 29.29 | 47 | 1,376 | 20,362 | 20.4 K to 20.4 K (-0.23 %) |
| Feb 26 2009 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 32.09 | 13,000 | 417,170 | 13,000 | |
| Feb 26 2009 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 32.09 | 2,143 | 68,769 | 8,605 | 6.5 K to 8.6 K (+33.16 %) |
| Dec 30 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 35.90 | 14 | 503 | 6,462 | 6.4 K to 6.5 K (+0.22 %) |
| Dec 15 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 36.00 | 14 | 504 | 6,449 | 6.4 K to 6.4 K (+0.22 %) |
| Dec 02 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 35.50 | 14 | 497 | 6,434 | 6.4 K to 6.4 K (+0.22 %) |
| Dec 01 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | D | 31.66 | 291 | 9,213 | 6,426 | 6.7 K to 6.4 K (-4.33 %) |
| Nov 17 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 35.16 | 14 | 492 | 6,713 | 6.7 K to 6.7 K (+0.21 %) |
| Nov 04 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 39.92 | 12 | 479 | 6,693 | 6.7 K to 6.7 K (+0.18 %) |
| Oct 20 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.39 | 12 | 485 | 6,654 | 6.6 K to 6.7 K (+0.18 %) |
| Oct 08 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 44.09 | 11 | 485 | 6,639 | 6.6 K to 6.6 K (+0.17 %) |
| Sep 22 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 51.66 | 10 | 517 | 6,623 | 6.6 K to 6.6 K (+0.15 %) |
| Sep 08 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 48.52 | 10 | 485 | 6,614 | 6.6 K to 6.6 K (+0.15 %) |
| Aug 27 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 49.25 | 3,000 | 147,750 | 20,409 | 23.4 K to 20.4 K (-12.82 %) |
| Aug 27 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 48.00 | 5,000 | 240,000 | 25,409 | 30.4 K to 25.4 K (-16.44 %) |
| Aug 25 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 49.10 | 10 | 491 | 6,604 | 6.6 K to 6.6 K (+0.15 %) |
| Aug 25 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 49.09 | 2,000 | 98,180 | 28,409 | 30.4 K to 28.4 K (-6.58 %) |
| Aug 12 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 49.50 | 10 | 495 | 6,594 | 6.6 K to 6.6 K (+0.15 %) |
| Jul 29 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 45.72 | 11 | 503 | 6,587 | 6.6 K to 6.6 K (+0.17 %) |
| Jul 23 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | D | 43.65 | 206 | 8,992 | 6,578 | 6.8 K to 6.6 K (-3.04 %) |
| Jul 15 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 43.59 | 11 | 479 | 6,763 | 6.8 K to 6.8 K (+0.16 %) |
| Jun 30 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 43.86 | 11 | 482 | 6,751 | 6.7 K to 6.8 K (+0.16 %) |
| Jun 16 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.95 | 10 | 480 | 6,736 | 6.7 K to 6.7 K (+0.15 %) |
| Jun 02 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.43 | 10 | 474 | 6,727 | 6.7 K to 6.7 K (+0.15 %) |
| May 20 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 46.34 | 11 | 510 | 6,716 | 6.7 K to 6.7 K (+0.16 %) |
| May 06 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 46.90 | 11 | 516 | 6,705 | 6.7 K to 6.7 K (+0.16 %) |
| Apr 21 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 46.94 | 10 | 469 | 6,674 | 6.7 K to 6.7 K (+0.15 %) |
| Apr 07 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 44.76 | 11 | 492 | 6,665 | 6.7 K to 6.7 K (+0.17 %) |
| Mar 24 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 43.70 | 11 | 481 | 6,656 | 6.6 K to 6.7 K (+0.17 %) |
| Mar 24 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 43.70 | 11 | 481 | 6,656 | 6.6 K to 6.7 K (+0.17 %) |
| Mar 11 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 39.70 | 12 | 476 | 6,645 | 6.6 K to 6.6 K (+0.18 %) |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 41.70 | 13,749 | 573,333 | 13,749 | |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.70 | 614 | 25,604 | 6,633 | 6 K to 6.6 K (+10.20 %) |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.70 | 3,490 | 145,533 | 6,019 | 2.5 K to 6 K (+138.00 %) |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.70 | 697 | 29,065 | 30,409 | 29.7 K to 30.4 K (+2.35 %) |
| Feb 25 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.66 | 12 | 488 | 2,529 | 2.5 K to 2.5 K (+0.48 %) |
| Feb 14 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Payment of Exercise | F | 38.38 | 96 | 3,684 | 29,712 | 29.8 K to 29.7 K (-0.32 %) |
| Feb 11 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 37.97 | 13 | 494 | 2,518 | 2.5 K to 2.5 K (+0.52 %) |
| Jan 28 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 37.93 | 13 | 493 | 2,505 | 2.5 K to 2.5 K (+0.52 %) |
| Jan 14 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.10 | 12 | 493 | 2,482 | 2.5 K to 2.5 K (+0.49 %) |
| Jan 02 2008 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.35 | 12 | 484 | 2,471 | 2.5 K to 2.5 K (+0.49 %) |
| Dec 17 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 37.88 | 13 | 492 | 2,459 | 2.4 K to 2.5 K (+0.53 %) |
| Dec 03 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 37.57 | 13 | 488 | 2,447 | 2.4 K to 2.4 K (+0.53 %) |
| Nov 19 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 39.29 | 12 | 471 | 2,433 | 2.4 K to 2.4 K (+0.50 %) |
| Nov 05 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 38.75 | 13 | 504 | 2,421 | 2.4 K to 2.4 K (+0.54 %) |
| Oct 23 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.01 | 12 | 480 | 2,399 | 2.4 K to 2.4 K (+0.50 %) |
| Oct 09 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.21 | 12 | 483 | 2,387 | 2.4 K to 2.4 K (+0.51 %) |
| Sep 24 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.08 | 12 | 493 | 2,374 | 2.4 K to 2.4 K (+0.51 %) |
| Sep 10 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.10 | 12 | 481 | 2,363 | 2.4 K to 2.4 K (+0.51 %) |
| Aug 27 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.72 | 12 | 489 | 2,351 | 2.3 K to 2.4 K (+0.51 %) |
| Aug 13 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.92 | 12 | 503 | 2,338 | 2.3 K to 2.3 K (+0.52 %) |
| Jul 31 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.23 | 10 | 472 | 2,325 | 2.3 K to 2.3 K (+0.43 %) |
| Jul 17 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 51.83 | 9 | 466 | 2,308 | 2.3 K to 2.3 K (+0.39 %) |
| Jul 03 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.15 | 10 | 472 | 2,299 | 2.3 K to 2.3 K (+0.44 %) |
| Jun 19 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 48.33 | 10 | 483 | 2,288 | 2.3 K to 2.3 K (+0.44 %) |
| Jun 04 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 51.35 | 9 | 462 | 2,277 | 2.3 K to 2.3 K (+0.40 %) |
| May 22 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 48.65 | 10 | 487 | 2,268 | 2.3 K to 2.3 K (+0.44 %) |
| May 08 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 51.78 | 9 | 466 | 2,258 | 2.2 K to 2.3 K (+0.40 %) |
| Apr 24 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.12 | 9 | 424 | 2,250 | 2.2 K to 2.3 K (+0.40 %) |
| Apr 11 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 46.78 | 9 | 421 | 2,235 | 2.2 K to 2.2 K (+0.40 %) |
| Mar 27 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.75 | 10 | 478 | 2,225 | 2.2 K to 2.2 K (+0.45 %) |
| Mar 13 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 42.29 | 10 | 423 | 2,217 | 2.2 K to 2.2 K (+0.45 %) |
| Mar 02 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Payment of Exercise | F | 45.35 | 47 | 2,131 | 29,732 | 29.8 K to 29.7 K (-0.16 %) |
| Mar 01 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 44.97 | 13,169 | 592,210 | 13,169 | |
| Mar 01 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 44.97 | 4,361 | 196,114 | 29,779 | 25.4 K to 29.8 K (+17.16 %) |
| Mar 01 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 44.77 | 813 | 36,398 | 25,418 | 24.6 K to 25.4 K (+3.30 %) |
| Feb 26 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 47.29 | 9 | 426 | 2,205 | 2.2 K to 2.2 K (+0.41 %) |
| Feb 12 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 48.22 | 9 | 434 | 2,196 | 2.2 K to 2.2 K (+0.41 %) |
| Jan 29 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 46.60 | 9 | 419 | 2,187 | 2.2 K to 2.2 K (+0.41 %) |
| Jan 17 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 48.19 | 9 | 434 | 2,171 | 2.2 K to 2.2 K (+0.42 %) |
| Jan 03 2007 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 51.87 | 6 | 311 | 2,161 | 2.2 K to 2.2 K (+0.28 %) |
| Dec 19 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 51.09 | 6 | 307 | 2,155 | 2.1 K to 2.2 K (+0.28 %) |
| Dec 04 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 48.38 | 7 | 339 | 2,149 | 2.1 K to 2.1 K (+0.33 %) |
| Nov 21 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 50.11 | 7 | 351 | 2,142 | 2.1 K to 2.1 K (+0.33 %) |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 14.70 | 18,000 | 264,658 | 0 | |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 47.20 | 18,000 | 849,560 | 24,411 | 42.4 K to 24.4 K (-42.44 %) |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 14.70 | 18,000 | 264,658 | 42,411 | 24.4 K to 42.4 K (+73.74 %) |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 14.70 | 20,000 | 294,064 | 18,000 | |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 46.14 | 20,000 | 922,872 | 24,411 | 44.4 K to 24.4 K (-45.03 %) |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 14.70 | 20,000 | 294,064 | 44,411 | 24.4 K to 44.4 K (+81.93 %) |
| Nov 07 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 44.83 | 7 | 314 | 2,136 | 2.1 K to 2.1 K (+0.33 %) |
| Oct 24 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 41.86 | 8 | 335 | 2,130 | 2.1 K to 2.1 K (+0.38 %) |
| Oct 10 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 40.20 | 8 | 322 | 2,116 | 2.1 K to 2.1 K (+0.38 %) |
| Sep 25 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 38.38 | 9 | 345 | 2,108 | 2.1 K to 2.1 K (+0.43 %) |
| Sep 11 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 39.96 | 8 | 320 | 2,099 | 2.1 K to 2.1 K (+0.38 %) |
| Aug 29 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 38.20 | 9 | 344 | 2,091 | 2.1 K to 2.1 K (+0.43 %) |
| Aug 17 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 14.70 | 10,000 | 147,032 | 38,000 | |
| Aug 17 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 38.30 | 10,000 | 383,011 | 32,764 | 42.8 K to 32.8 K (-23.38 %) |
| Aug 17 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 14.70 | 10,000 | 147,032 | 42,764 | 32.8 K to 42.8 K (+30.52 %) |
| Aug 14 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 37.27 | 9 | 335 | 2,083 | 2.1 K to 2.1 K (+0.43 %) |
| Aug 01 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 38.32 | 9 | 345 | 2,074 | 2.1 K to 2.1 K (+0.44 %) |
| Jul 17 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 32.03 | 10 | 320 | 2,060 | 2.1 K to 2.1 K (+0.49 %) |
| Jul 05 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 36.28 | 9 | 327 | 2,049 | 2 K to 2 K (+0.44 %) |
| Jun 19 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 34.72 | 9 | 312 | 2,040 | 2 K to 2 K (+0.44 %) |
| Jun 05 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 35.15 | 9 | 316 | 2,031 | 2 K to 2 K (+0.45 %) |
| May 31 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | D | 34.70 | 3,400 | 117,980 | 32,681 | 36.1 K to 32.7 K (-9.42 %) |
| May 31 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | D | 34.90 | 247 | 8,620 | 36,081 | 36.3 K to 36.1 K (-0.68 %) |
| May 22 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 35.66 | 9 | 321 | 2,021 | 2 K to 2 K (+0.45 %) |
| May 08 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 37.45 | 8 | 300 | 2,011 | 2 K to 2 K (+0.40 %) |
| May 03 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 36.28 | 6,000 | 217,701 | 36,328 | 42.3 K to 36.3 K (-14.18 %) |
| May 03 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 13.38 | 6,000 | 80,250 | 42,328 | 36.3 K to 42.3 K (+16.52 %) |
| Apr 24 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 33.35 | 9 | 300 | 2,005 | 2 K to 2 K (+0.45 %) |
| Apr 10 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 35.03 | 8 | 280 | 1,988 | 2 K to 2 K (+0.40 %) |
| Mar 28 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 33.29 | 9 | 300 | 1,981 | 2 K to 2 K (+0.46 %) |
| Mar 14 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 31.20 | 9 | 281 | 1,950 | 1.9 K to 2 K (+0.46 %) |
| Mar 02 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 13.38 | 10,000 | 133,750 | 6,000 | |
| Mar 02 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Payment of Exercise | F | 32.53 | 1,802 | 58,619 | 39,501 | 41.3 K to 39.5 K (-4.36 %) |
| Mar 02 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Payment of Exercise | F | 32.53 | 4,112 | 133,763 | 41,303 | 45.4 K to 41.3 K (-9.05 %) |
| Mar 02 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 13.38 | 10,000 | 133,750 | 45,415 | 35.4 K to 45.4 K (+28.24 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | A | 32.59 | 9,282 | 302,454 | 9,282 | |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 25.20 | 11 | 277 | 2,552 | 2.5 K to 2.6 K (+0.43 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 0.00 | 950 | 0 | 35,415 | 34.5 K to 35.4 K (+2.76 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 32.59 | 665 | 21,669 | 34,465 | 33.8 K to 34.5 K (+1.97 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 0.00 | 3,173 | 0 | 33,800 | 30.6 K to 33.8 K (+10.36 %) |
| Feb 14 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 29.08 | 10 | 291 | 1,954 | 1.9 K to 2 K (+0.51 %) |
| Jan 30 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 30.92 | 9 | 278 | 1,944 | 1.9 K to 1.9 K (+0.47 %) |
| Jan 18 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 28.22 | 10 | 282 | 1,936 | 1.9 K to 1.9 K (+0.52 %) |
| Jan 03 2006 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 25.03 | 12 | 300 | 1,920 | 1.9 K to 1.9 K (+0.63 %) |
| Dec 20 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 24.50 | 12 | 294 | 1,908 | 1.9 K to 1.9 K (+0.63 %) |
| Dec 05 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 25.67 | 11 | 282 | 1,897 | 1.9 K to 1.9 K (+0.58 %) |
| Nov 25 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 25.40 | 7,900 | 200,684 | 30,321 | 38.2 K to 30.3 K (-20.67 %) |
| Nov 22 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 25.89 | 11 | 285 | 1,886 | 1.9 K to 1.9 K (+0.59 %) |
| Nov 07 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 23.78 | 12 | 285 | 1,915 | 1.9 K to 1.9 K (+0.63 %) |
| Oct 24 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 23.27 | 12 | 279 | 1,903 | 1.9 K to 1.9 K (+0.63 %) |
| Oct 11 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 28.38 | 10 | 284 | 1,840 | 1.8 K to 1.8 K (+0.55 %) |
| Sep 26 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 29.05 | 10 | 291 | 1,830 | 1.8 K to 1.8 K (+0.55 %) |
| Sep 12 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 25.09 | 10 | 251 | 1,820 | 1.8 K to 1.8 K (+0.55 %) |
| Sep 01 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Option Exercise | M | 11.30 | 10,000 | 112,950 | 0 | |
| Sep 01 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Sell | S | 28.26 | 10,000 | 282,643 | 38,221 | 48.2 K to 38.2 K (-20.74 %) |
| Sep 01 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Buy | M | 11.30 | 10,000 | 112,950 | 48,221 | 38.2 K to 48.2 K (+26.16 %) |
| Aug 30 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 26.80 | 11 | 295 | 1,811 | 1.8 K to 1.8 K (+0.61 %) |
| Aug 16 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 26.62 | 11 | 293 | 1,800 | 1.8 K to 1.8 K (+0.61 %) |
| Aug 02 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 27.24 | 11 | 300 | 1,789 | 1.8 K to 1.8 K (+0.62 %) |
| Jul 19 2005 | WST | WEST PHARMACEUTICA ... | GAILEY JOHN R | VP, Gen. Counsel & ... | Grant | A | 27.86 | 10 | 279 | 1,771 | 1.8 K to 1.8 K (+0.57 %) |